Eli Lilly and Company (NYSE:LLY) Q1 2014 Results Earnings Conference Call April 24, 2014 9:00 AM ET
Executives
John Lechleiter - Chairman, President, and CEO
Derica Rice - Chief Financial Officer
Dr. Jan Lundberg - President of Lilly Research Laboratories
Sue Mahony - President of Lilly Oncology
Enrique Conterno - President of Lilly Diabetes
Dave Ricks - President of Lilly Bio-Medicines
Jeff Simmons - President of Elanco Animal Health
Phil Johnson - Investor Relations
Analysts
Chris Schott - JPMorgan
Tim Anderso - Sanford Bernstein
Mark Schoenebaum - ISI Group
Steve Scala - Cowen
John Boris - SunTrust Robinson Humphrey
Jami Rubin - Goldman Sachs
David Risinger - Morgan Stanley
Jeff Holford - Jefferies
Marc Goodman - UBS
Vamil Divan - Credit Suisse
Alex Arfaei - BMO Capital Markets
Colin Bristow - Bank of America Merrill Lynch
Damien Conover - Morningstar
Seamus Fernandez - Leerink Swann
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Eli Lilly First Quarter 2014 Earning Call. For the conference all participants are in a listen-only mode. There will be an opportunity for your questions and instructions will be given at that time. (Operator Instructions). And as a reminder, today’s call is being recorded.
I will turn the conference now over to your host, Mr. John Lechleiter, Chairman, President, and CEO. Please go ahead sir.
John Lechleiter
Good morning everyone. Thank you for joining us for the second time this week, today to discuss Eli Lilly & Company's first quarter 2014 earnings. I’m John Lechleiter, Chairman, President, and CEO. This quarter and going forward we're taking a slightly different approach to our quarterly calls, we are bringing more of our senior leaders into the room to participate and to answer your questions and we hope that this enhances the quality of the information we are able to provide you during these
- Read more current LLY analysis and news
- View all earnings call transcripts